Health News

Younger Men Benefit From Surgery
New research has suggested that older men diagnosed with prostate cancer may not need any treatment. Now, a 15-year study shows that surgery is the best option for men under the age of 65.
FDA approves Zytiga for late-stage prostate cancer
The U.S. Food and Drug Administration (FDA) today approved Zytiga ( abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).
Dietary Fats and Prostate Health
You can't turn around without hearing praise for the health benefits of omega-3 fatty acids. Likewise, trans-fatty acids are considered one of the most unhealthful substances we can eat. Well, hold your horses - when it comes to prostate health, all that's wrong!
Some Prostate Cancers Don't Need to be Treated
Men aged 65 and older who are diagnosed with a low-risk form of prostate cancer don't need to jump right into treatment. Delaying surgery and radiation doesn't pose added risk of death as long as the cancer is closely monitored.
New Test Detects Prostate Cancer More Accurately
A large clinical trial has demonstrated a new screening for prostate cancer that's more accurate than the tests currently available. In research conducted by Northwestern Medicine, the new PSA test reduced the number of false positives and pinpointed prostate cancer more precisely, particularly the aggressive form of the disease.
Diabetes Increases Risks of Cancer
A new study shows that avoiding or controlling diabetes may reduce risks of developing or dying from cancer.
Learning from History
In recognition of Black History Month we're taking a look at diseases for which African-Americans are at higher risk -- and what to do about them.
Certain Prostate Cancer Tumors More Likely to Metastasize
Certain prostate tumors have the potential to become metastatic if not treated aggressively, according to new research from Dana-Farber Cancer Institute.
New Therapy May Halt Prostate Cancer
A new RNA therapy has been shown to prevent prostate-cancer stem cells from replicating, thanks to new research from University of Texas MD Anderson Cancer Center.
The Little Gene that Could
The protein known as SIRT1 -- known for its life-spanning effects -- has been shown to inhibit prostatic intraepithelial neoplasia (PIN), which often prefigures prostate cancer.